Get the Stockscreener App
18.18
2.89%
0.51
After Hours:
18.23
0.05
+0.28%
Cargo Therapeutics Inc stock is traded at $18.18, with a volume of 110.09K.
It is up +2.89% in the last 24 hours and down -19.31% over the past month.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
See More
Previous Close:
$17.67
Open:
$17.77
24h Volume:
110.09K
Relative Volume:
0.40
Market Cap:
$836.78M
Revenue:
-
Net Income/Loss:
$-147.71M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$-127.89M
1W Performance:
+12.01%
1M Performance:
-19.31%
6M Performance:
+0.78%
1Y Performance:
+17.75%
1-Day Range:
$17.64
$18.46
1-Week Range:
$15.90
$18.46
52-Week Range:
$13.56
$33.92
Cargo Therapeutics Inc Stock (CRGX) Company Profile
Name
Cargo Therapeutics Inc
Sector
Industry
Phone
650-499-8950
Address
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
Compare CRGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRGX
Cargo Therapeutics Inc
|
18.18 | 836.78M | 0 | -147.71M | -127.89M | -3.5857 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.13 | 120.56B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
750.22 | 82.44B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
616.55 | 36.87B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.07 | 32.64B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.39 | 28.38B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-26-24 | Initiated | William Blair | Outperform |
| Jul-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-08-24 | Initiated | Chardan Capital Markets | Buy |
| Jun-27-24 | Initiated | Piper Sandler | Overweight |
| Dec-05-23 | Initiated | JP Morgan | Overweight |
| Dec-05-23 | Initiated | Jefferies | Buy |
| Dec-05-23 | Initiated | TD Cowen | Outperform |
| Dec-05-23 | Initiated | Truist | Buy |
View All
Cargo Therapeutics Inc Stock (CRGX) Latest News
CARGO Therapeutics (NASDAQ:CRGX) Earns Outperform Rating from Analysts at William Blair - Defense World
Sio Capital Management LLC Takes Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - MarketBeat
Equities Analysts Set Expectations for CRGX FY2024 Earnings - Defense World
FY2024 Earnings Estimate for CRGX Issued By William Blair - MarketBeat
Here's Why We're Not Too Worried About CARGO Therapeutics' (NASDAQ:CRGX) Cash Burn Situation - Simply Wall St
Analyzing JATT Acquisition (NYSE:JATT) and CARGO Therapeutics (NASDAQ:CRGX) - Defense World
Five new option listings on November 27th - TipRanks
William Blair Initiates Coverage of CARGO Therapeutics (CRGX) with Outperform Recommendation - MSN
Cargo Therapeutics draws bullish view at William Blair on lead asset - MSN
Cargo Therapeutics stock wins over William Blair - Seeking Alpha
Alexandria Inks 259 KSF Bay Area Life Science Lease - Commercial Property Executive
Companies get creative with multi-targeted CARs at SITC, ASH - BioCentury
Long Term Trading Analysis for (CRGX) - Stock Traders Daily
CARGO Therapeutics (NASDAQ:CRGX) Earns Buy Rating from HC Wainwright - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Earns Buy Rating from Chardan Capital - Defense World
Janus Henderson Group PLC's Strategic Acquisition in Cargo Thera - GuruFocus.com
RTW INVESTMENTS, LP Expands Stake in Cargo Therapeutics Inc - GuruFocus.com
CARGO Therapeutics Advances in Cancer Therapy Development - TipRanks
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
Reviewing CARGO Therapeutics (CRGX) & The Competition - Defense World
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Average Rating of “Buy” from Analysts - Defense World
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Critical Comparison: CARGO Therapeutics (CRGX) and Its Rivals - Defense World
How to Take Advantage of moves in (CRGX) - Stock Traders Daily
CARGO Therapeutics (CRGX) & The Competition Financial Survey - Defense World
CARGO Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, - GlobeNewswire
CARGO Therapeutics CEO to Present at Major Healthcare Investor Conferences | CRGX Stock News - StockTitan
Apple Inc (AAPL-Q) QuotePress Release - The Globe and Mail
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
Dow Jones Industrials Average (DOWI) QuotePress Release - The Globe and Mail
TSX Preferred Share Index (TXPR) QuotePress Release - The Globe and Mail
S&P 500 Energy [Sector] (SREN) QuotePress Release - The Globe and Mail
TSX Global Gold EW Index (TXGE) QuotePress Release - The Globe and Mail
Microsoft Corp (MSFT-Q) QuotePress Release - The Globe and Mail
Nasdaq US MD Cap Telecom Index USD (NQTI) QuotePress Release - The Globe and Mail
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity - StockTitan
US Midwest Busheling (THN25) Quote - The Globe and Mail
Alphabet Cl A (GOOGL-Q) QuotePress Release - The Globe and Mail
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Short Interest Up 7.1% in October - MarketBeat
Twilio (TWLO-N) QuotePress Release - The Globe and Mail
S&P 100 Index (OEX) QuotePress Release - The Globe and Mail
Where are the Opportunities in (CRGX) - Stock Traders Daily
Reviewing CARGO Therapeutics (CRGX) & Its Rivals - Defense World
Nvelop Therapeutics to Present at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference - Business Wire
Creative Planning Has $19.65 Million Stake in Global X U.S. Preferred ETF (NYSEARCA:PFFD) - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Trading Down 5.9%Here's What Happened - MarketBeat
Becker Logistics study exposes cargo theft risk tied to lax security - Yahoo Finance
Seelos Therapeutics (NASDAQ:SEEL) and Zoetis (NYSE:ZTS) Head-To-Head Contrast - Defense World
(CRGX) Long Term Investment Analysis - Stock Traders Daily
Emirates Boosts Cargo Fleet with New Boeing 777F Order as Freight Demand Surges - Yahoo Finance
Cargo Therapeutics Inc Stock (CRGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):